“Deucravacitinib in Plaque Psoriasis: 3-Year Safety and Efficacy Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials”. SKIN The Journal of Cutaneous Medicine 7, no. 6 (November 13, 2023): s240. Accessed April 4, 2025. https://skin.dermsquared.com/skin/article/view/2359.